FDA Inspection 1210670 — Pennsylvania State University IRB
The FDA completed an inspection of Pennsylvania State University IRB on July 18, 2023 in University Park, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 18, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- University Park, PA (United States)
Additional Details
IRB